NeuroBo Pharmaceuticals, Inc. Annual Costs and Expenses in USD from 2014 to 2023

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
NeuroBo Pharmaceuticals, Inc. quarterly/annual Costs and Expenses history and growth rate from 2014 to 2023.
  • NeuroBo Pharmaceuticals, Inc. Costs and Expenses for the quarter ending September 30, 2024 was $6.26M, a 60.8% increase year-over-year.
  • NeuroBo Pharmaceuticals, Inc. Costs and Expenses for the twelve months ending September 30, 2024 was $28.9M, a 39.9% increase year-over-year.
  • NeuroBo Pharmaceuticals, Inc. annual Costs and Expenses for 2023 was $15.9M, a 19.1% decline from 2022.
  • NeuroBo Pharmaceuticals, Inc. annual Costs and Expenses for 2022 was $19.6M, a 28.3% increase from 2021.
  • NeuroBo Pharmaceuticals, Inc. annual Costs and Expenses for 2021 was $15.3M, a 48.5% decline from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Annual (USD)
Costs and Expenses, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $15.9M -$3.74M -19.1% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-28
2022 $19.6M +$4.33M +28.3% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-28
2021 $15.3M -$14.4M -48.5% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-30
2020 $29.7M +$9.54M +47.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-31
2019 $20.2M +$4.69M +30.3% Jan 1, 2019 Dec 31, 2019 10-K 2021-04-15
2018 $15.5M -$17.6M -53.2% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 $33.1M +$18.4M +125% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $14.7M +$6.62M +82% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $8.08M +$7.81M +2936% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-20
2014 $266K Jan 1, 2014 Dec 31, 2014 10-K 2017-03-21
* An asterisk sign (*) next to the value indicates that the value is likely invalid.